fort has now been terminated in favor of open-cycle and electrolytic approaches.
theoretical 56.7 kcal, considering possible inaccuracies in thermodynamic data and the simplified analysis. A proper analysis of processes A and C leads to the same conclusion.
The 14000K thermochemical cycle proposed by Soliman et al. is quite similar to one that we evaluated earlier in our laboratory, and we agree that it looks relatively attractive on a heat efficiency basis. However, we hold to our earlier opinion that a limit of 12000K seems realistic for safe process heat delivered across a heat exchanger in commercial reactors for the next two decades. For 12000K maximum, the identified thermochemical cycles based on sulfates appear to involve unnecessary penalties in energy consumption. If the serious problems of heat exchanger integrity, corrosion, and containment of radioactive species at the 14000K level can be solved, then the cycle of Soliman et al. or some other cycle could form the basis for a successful water-splitting process. Such a cycle might require integration in certain temperature ranges.
In summary, the basic concept of closedcycle thermochemical hydrogen processes is sound but further detailed study will be required to determine whether they are practically and technically feasible and whether they will ever compete economically with electrolysis or other hydrogen production methods in the long term.
R (4, 5) . Intravenous injections of polymers may easily deliver an amount of iron to the blood that greatly exceeds the iron-binding capacity of transferrin (6) before they are cleared from the circulation by the reticuloendothelial cells, which may then release a portion of this iron to transferrin for several days (7). After intramuscular or intraperitoneal injection of iron polymers, serum iron may equal or exceed the total iron-binding capacity for a few hours while the polymers are absorbed intact into the lymphatics (8) . Such high concentrations of iron in the serum are only transient, but significant amounts of polymeric iron are meanwhile available for microbial growth. Under these circumstances, transferrin "saturations" have no physiological meaning. The data (6, 9) simply demonstrate that microorganisms can thrive on polymeric iron. The implications of these data should not be extrapolated to any but iatrogenic situations.
Stoichiometric Fe(IIl)-transferrin complexes are formed in vitro only when the ferric ion is presented to the protein in a suitably chelated form, for example, as iron nitrilotriacetate (10) . Unfortunately, many widely used methods of saturatingtransferrin in vitro, including most current clinical procedures for measuring the total iron-binding capacity of human serum,-continue to require inorganic ferrous or ferric salts as iron donors. Under such conditions, with 02 present, ferrous ion is oxidized at a rapid rate at neutral pH, especially in the presence of serum transferrin or ceruloplasmin (11) . The ferric ion formed by this oxidation immediately hydrolyzes to form polynuclear, high-molecular-weight complexes (12) . When inorganic ferric salts are used to saturate transferrin, they rapidly hydrolyze to polymeric species and are in large part bound nonspecifically to the protein. All attempts to "saturate" transferrin with inorganic iron salts force the utilization of far more than stoichiometric amounts of iron to fill the two binding sites (5) . The excess iron is present in a polynuclear form and is nutritlonally available to microorganisms in vitro (13, 14) .
As Weinberg noted (2), orally administered iron is generally not effective in promoting systemic infection. It is nearly impossible to saturate the transferrin of normal individuals by therapeutic oral doses of iron, partly because transferrin-bound iron is turned over rapidly in serum (15) . Transferrin is not found fully saturated even after excessive intake of dietary iron in the rat (16) Between 1967 and 1973, nearly all Polynesian infants born in hospitals in the Napier-Hastings area of New Zealand were given iron dextran intramuscularly for 5 days starting on the second day of life. This practice has been stopped because the incidence of Gram-negative bacterial septicemias and meningitis that subsequently occurred in the iron-stressed infants was eightfold higher than in nontreated infants. The great majority of affected children were healthy at birth, of average weight, and did not suffer any recognized perinatal event likely to lead to infection. The clinicians concluded that "the safety of routine iron injections . . . must be seriously questioned" (3) .
In kwashiorkor, patients are unusually susceptible to infection despite their continued ability to synthesize normal amounts of immune globulins. In contrast, their serum levels of transferrin are depressed; in patients with poor prognoses, the level is as low as 10 percent of normal.
Intramuscular injection of iron compounds in some of these patients has resulted in overwhelming infection and death. The clinicians concluded that iron therapy should be delayed until transferrin synthesis could be restored by appropriate protein nutrition (4).
In feeding studies with rat (5) and guinea pig (6) nurslings suckled animals developed normally, whereas all of the rats and some of the guinea pigs fed iron-supplemented milk formula developed diarrhea and died. Lactoferrin in colostrum and in maternal milk is an important antibacterial component provided that it is not saturated with iron (7). When guinea pig milk was supplemented with iron in the form of hematin, the number of coliform bacteria in the small intestine of the nurslings was increased by 10,000-fold (6) . In tests in vitro (5) , the powerful bacteriostatic action of human milk on coliform bacteria was neutralized by the same quantities (I to 10
Mgg/ml) of supplemental iron that are incorporated in milk formulas fed to human infants (8) .
Human infants with low birth weight and that have suffered an injury to the intestinal mucosa often develop a fatal necrotizing enterocolitis provided that they are fed milk formula rather than fresh human milk (5) . Results of the studies with milk, cited above, suggest that the disease could be prevented or suppressed if the diet of the infants were to be supplemented with lactoferrin. Human lactoferrin has a greater affinity for iron as compared to bovine lactoferrin (9), but, of course, the latter would be more readily obtainable. Banked human milk is usually autoclaved or frozen so that its lactoferrin content might be somewhat reduced from that in fresh human milk.
In his well-reasoned review, Sussman (2) stated that a considerable body of evidence is accumulating to suggest that "iron plays an important part in determining virulence and possibly even pathogenicity in experimental infections." Fortunately, the serum ferritin method (10) 
